Icon Legend

This session is not in your schedule.

This session is in your schedule. Click again to remove it.

Session Icons

Live Streamed

On Demand

184 Views

A6. New drug development (formerly L3)

Poster Session: New Drug Development

(P-1169) Obeldesivir and GS-441524 Antiviral Activity against L Protein Mutants in Respiratory Syncytial Virus (RSV) Minigenome and Recombinant Infectious Virus Systems

Tuesday, October 21, 2025

12:15 PM - 1:30 PM US ET

Location: Poster Hall B4-B5

Presenting Author(s)

JR

J. Lizbeth Reyes Zamora, PhD

Gilead Sciences, Inc.
Foster City, California, United States
DH

Dong Han, MS

Gilead Sciences, Inc.
Foster City, California, United States
JC

Josolyn Chan, MS

Gilead Sciences, Inc.
Foster City, California, United States
NP

Nadine Peinovich, MPH

Gilead Sciences, Inc.
Foster City, California, United States
CR

Christopher Richards, PhD

Gilead Sciences, Inc.
Foster City, California, United States
SE

Stacey Eng, BS

Gilead Sciences, Inc.
Foster City, California, United States
JB

John P. Bilello, PhD

Gilead Sciences, Inc.
Foster City, California, United States
Charlotte Hedskog, PhD (she/her/hers)

Senior Research Scientist
Gilead Sciences, Inc.
Foster City, California, United States